TRUALT - TruAlt Bioenergy
π’ Recent Corporate Announcements
India Ratings has assigned a first-time 'IND A-' rating with a stable outlook to TruAlt Bioenergy's βΉ1,766 crore bank facilities, citing its position as India's largest ethanol producer with a 2,000 klpd capacity. The company has a strong order book to supply 505 million liters in ESY26, which is expected to drive significant revenue growth in FY27. While the company is undergoing a large βΉ10.5 billion capex for Compressed Biogas (CBG) plants, its recent βΉ7.5 billion IPO fresh issue has strengthened the balance sheet. Analysts expect net leverage to improve to below 3.5x by FY27 as new capacities and grain-based feedstock integration stabilize.
- Assigned 'IND A-/Stable' and 'IND A2+' ratings for βΉ17,660 million bank loan facilities.
- India's largest cane-based distillery with 2,000 klpd capacity and a 505 mnL ethanol order book for ESY26.
- 9MFY26 consolidated revenue grew 13% YoY to βΉ11.2 billion with EBITDA of βΉ1.9 billion.
- Planned βΉ10.5 billion capex for 21 CBG plants in JVs with GAIL India and Sumitomo Corporation.
- Net leverage expected to improve from 4.5x in FY25 to below 3.5x by FY27 following IPO fund utilization.
TruAlt Bioenergy Limited has submitted its quarterly compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations for the period ending March 31, 2026. The company's Registrar, Bigshare Services Private Limited, confirmed that no requests for dematerialization or rematerialization were received during the quarter. Notably, the filing confirms that 100% of the company's shares are already held in dematerialized form. This is a standard administrative disclosure required for all listed entities in India.
- Compliance certificate filed for the quarter and year ended March 31, 2026.
- 100% of the company's shareholding is currently maintained in dematerialized form.
- Zero requests for dematerialization or rematerialization were processed during the quarter.
TruAlt Bioenergy Limited has updated its list of Key Managerial Personnel (KMP) authorized to determine the materiality of events under SEBI (LODR) Regulations. Mr. Monu Kumar, the Company Secretary and Compliance Officer, has been newly designated for this role alongside existing senior management. The updated list now includes five key officials, including the Managing Director, Executive Director, and CFO. Any two of these authorized persons jointly, including at least one Executive Director, are responsible for making necessary disclosures to stock exchanges.
- Mr. Monu Kumar (Company Secretary) designated as an authorized person under Regulation 30(5) of SEBI LODR.
- Total of 5 Key Managerial Personnel now authorized to determine event materiality.
- Disclosures require joint authorization by two KMPs, with one being an Executive Director.
- The board meeting regarding this administrative update concluded on March 30, 2026, at 1:50 P.M.
TruAlt Bioenergy Limited has announced the closure of its trading window for designated persons starting April 1, 2026. This action is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, ahead of the Q4 and full-year financial results for the period ending March 31, 2026. The trading restriction will remain in place until 48 hours after the audited financial results are officially declared. The company will announce the specific date for the board meeting to approve these results at a later time.
- Trading window closure effective from Wednesday, April 1, 2026
- Closure relates to the Audited Financial Results for Q4 and FY ending March 31, 2026
- Restriction applies to all Designated Persons and their immediate relatives
- Window to reopen 48 hours after the announcement of financial results
GAIL (India) Limited has invested βΉ130 million in TruAlt Bioenergy's subsidiary, Leafiniti Bioenergy, to acquire a 49% equity stake. This strategic partnership will fund the first phase of a joint venture to establish six greenfield Compressed Biogas (CBG) plants with a combined annual capacity of 23,976 tonnes. The collaboration combines TruAlt's bioenergy expertise with GAIL's extensive gas infrastructure and market reach. Beyond energy, the plants are expected to produce over 5.6 lakh tonnes of organic manure annually, enhancing the company's circular economy revenue streams.
- GAIL acquires 49% stake in subsidiary Leafiniti Bioenergy for βΉ130 million investment.
- Phase 1 includes 6 greenfield plants with 12 tonnes per day capacity each, totaling 23,976 tonnes of CBG annually.
- Projects expected to generate 97,902 tonnes of FOM and 4,70,862 tonnes of Liquid FOM annually.
- Joint venture targets expansion across Karnataka, Maharashtra, and Odisha to displace 19,800 tonnes of fossil fuels per year.
- TruAlt Bioenergy retains a 51% controlling stake in the subsidiary post-transaction.
TruAlt Bioenergy reported a robust 70% YoY growth in Q3 total income to βΉ730.86 crore, driven by the commissioning of its fifth ethanol unit. While 9M PAT grew marginally to βΉ35.92 crore, the company has established a monthly revenue run rate of βΉ350-400 crore in the ethanol segment. The CBG business remains highly profitable with a 63% EBITDA margin, and the company is scaling up with 24 new units via JVs with GAIL and Sumitomo. Management expects stronger momentum in Q4 as capacity utilization stabilizes across all units.
- Total income for Q3 FY26 rose 70% YoY to βΉ730.86 crore; 9M income reached βΉ1,187 crore.
- Ethanol segment achieved a monthly revenue run rate of βΉ350-400 crore with all 5 plants now operational.
- CBG business reported robust 9M EBITDA margins of 63% and PAT margins of 43%.
- Planned expansion of 24 Greenfield CBG units through JVs with Sumitomo and GAIL over 2-3 years.
- Advancing a 100 million liters per annum Sustainable Aviation Fuel (SAF) facility in Andhra Pradesh.
TruAlt Bioenergy Limited has officially released the audio recording of its earnings conference call held on February 09, 2026. The call focused on the company's unaudited standalone and consolidated financial results for the third quarter and nine months ended December 31, 2025. This disclosure is a routine regulatory requirement under SEBI LODR Regulations to ensure transparency for shareholders. Investors can access the full recording via the company's investor relations website to review management's commentary on operational performance.
- Audio recording of the Q3 FY26 earnings call is now accessible to the public via the company website.
- The call discussed financial performance for the quarter and nine-month period ending December 31, 2025.
- The interaction with analysts and institutional investors took place on February 09, 2026, at 1:00 PM IST.
- Compliance filing made under Regulation 30 and 46 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
TruAlt Bioenergy has received a favorable ruling from the Honβble High Court of Karnataka regarding a shortfall in ethanol supply to Oil Marketing Companies (OMCs). The court has directed OMCs to consider the company's request for a 90-day extension to supply 1,56,292 KL of ethanol originally allocated for Q3 and Q4 of ESY 2024-25. This quantity carries an estimated value of approximately βΉ1,075 crore, and the extension would allow the company to fulfill its contractual obligations and recognize the associated revenue. The OMCs are required to decide on the company's representation within 10 days of the order receipt.
- High Court of Karnataka allowed the writ petition for a 90-day extension to supply ethanol shortfall.
- The dispute involves 1,56,292 KL of ethanol allocated for the Third and Fourth quarters of ESY 2024-25.
- The estimated value of the contracted quantity under consideration is approximately βΉ1,075 crore.
- OMCs including BPCL, HPCL, and IOCL are directed to consider the representation within 10 days.
- Successful fulfillment of these quantities is expected to have a positive impact on the company's financial performance.
TruAlt Bioenergy reported a robust 69.75% YoY growth in total income to βΉ730.86 crore for Q3 FY26, driven by the commissioning of grain-based integration and expanded plant operations. While EBITDA grew 7.54% to βΉ134 crore, PAT saw a slight decline of 7.98% to βΉ69.19 crore due to transitional operating factors. The company has achieved full operational status for all five ethanol plants, positioning it for near year-round production. Strategic expansions are underway in Compressed Biogas (CBG) with 24 planned units and a 100 million litre Sustainable Aviation Fuel (SAF) project.
- Total income increased 69.75% YoY to βΉ730.86 crore in Q3 FY26.
- EBITDA rose to βΉ134.00 crore, though consolidated EBITDA margins compressed to 18.79% from 30.02% YoY.
- Ethanol production capacity stabilized at 5.5 to 6 crore litres per month with all 5 units now operational.
- CBG segment recorded 63% EBITDA margins for 9M FY26 with plans for 24 greenfield units via JVs with GAIL and Sumitomo.
- Progressing on a 100 million litres per annum SAF facility in Andhra Pradesh with Honeywell UOP technology.
TruAlt Bioenergy Limited has announced its earnings conference call to discuss financial results for the quarter and nine months ended December 31, 2025. The call is scheduled for Monday, February 9, 2026, at 1:00 P.M. IST. As India's largest ethanol producer by installed capacity, the management is expected to provide updates on its core ethanol business and expansion into Sustainable Aviation Fuel (SAF) and Compressed Bio Gas (CBG). The session will include a Q&A for analysts and institutional investors.
- Earnings call scheduled for February 9, 2026, at 1:00 P.M. IST to discuss Q3 FY26 results.
- Company is India's largest ethanol producer by installed capacity.
- Management to discuss performance across Ethanol, CBG, and upcoming 2G Ethanol and SAF ventures.
- Universal dial-in numbers for the call are +91 22 6280 1488 and +91 22 7115 8869.
- Audio recordings and transcripts will be made available on the company's website post-call.
TruAlt Bioenergy reported a 13.28% YoY growth in consolidated total income to βΉ1,187.05 crore for the nine months ended December 31, 2025. While EBITDA grew by 10% to βΉ170.99 crore, PBT saw a marginal decline of 4.72% due to higher finance costs and depreciation following the commissioning of new grain-based capacities. The company has successfully transitioned to a year-round multi-feed platform, achieving a monthly revenue run rate of βΉ350-400 crore in its ethanol segment.
- Consolidated 9M FY26 Total Income reached βΉ1,187.05 Cr with a PAT of βΉ35.92 Cr.
- Ethanol capacity reached 2,000 KLPD with 65% dual-feed integration, enabling near year-round operations.
- CBG segment demonstrated high profitability with an EBITDA margin of 63% and PAT margin of 43% for 9M FY26.
- Proposed βΉ2,250 Cr investment in a 100 million liters/annum Sustainable Aviation Fuel (SAF) facility in Andhra Pradesh.
- Retail fuel network expanded to 7 operational outlets with a target to scale to 75 outlets in FY27.
TruAlt Bioenergy Limited has announced a group meeting with analysts and institutional investors scheduled for February 9. The physical meeting is set to take place at Taj Santacruz, Mumbai, from 10:00 AM to 1:00 PM IST. The company has clarified that the discussion will be based strictly on publicly available information, ensuring no unpublished price-sensitive information is disclosed. This meeting is part of the company's routine engagement with the investment community under SEBI LODR regulations.
- Group meeting with analysts and investors scheduled for February 9.
- The interaction will be held physically at Taj Santacruz, Mumbai.
- Meeting duration is scheduled for 3 hours between 10:00 AM and 1:00 PM IST.
- Company confirms compliance with Regulation 30 of SEBI (LODR) Regulations, 2015.
TruAlt Bioenergy Limited has appointed Mr. Monu Kumar as its Company Secretary and Compliance Officer, effective February 03, 2026. Mr. Kumar is a qualified CS and Law Graduate with over 11 years of experience in corporate governance and regulatory compliance. He joins from Kurl-On Enterprise Limited (a subsidiary of Sheela Foam Limited) and has extensive experience with SEBI and RBI regulations. This appointment ensures the company remains compliant with SEBI (LODR) Regulations and the Companies Act, 2013.
- Appointment of Mr. Monu Kumar as Company Secretary and Compliance Officer effective February 03, 2026.
- Mr. Kumar brings over 11 years of professional experience in secretarial, legal, and regulatory domains.
- Expertise spans SEBI (LODR) Regulations, Companies Act 2013, FEMA, and IPO-related matters.
- Previous experience includes roles at Kurl-On Enterprise Limited and Rungta Irrigation Limited.
TruAlt Bioenergy reported a robust 71.8% year-on-year growth in consolidated revenue, reaching βΉ71,323.75 lakhs for the quarter ended December 31, 2025. Despite the revenue jump, net profit saw a slight decline of 8% to βΉ6,918.95 lakhs compared to βΉ7,519.22 lakhs in the same period last year, primarily due to higher finance costs and operational seasonality. This marks the company's first full quarter of reporting since its listing in October 2025. The company also progressed on its Joint Venture with Sumitomo Corporation and is awaiting regulatory clearance for its Unit 5 facility.
- Consolidated Revenue from Operations increased to βΉ71,323.75 lakhs from βΉ41,511.40 lakhs YoY.
- Net Profit for Q3 FY26 stood at βΉ6,918.95 lakhs with an EPS of βΉ8.07.
- Utilized βΉ51,937 lakhs of the βΉ75,000 lakhs IPO proceeds for capex and working capital.
- Executed a Joint Venture agreement with Sumitomo Corporation for a 49% stake in TruAlt Gas Private Limited.
- Unit 5 remains non-operational pending 'Consent to Operate' (CTO) from regulatory authorities.
TruAlt Bioenergy reported a significant turnaround in Q3 FY26, posting a consolidated net profit of βΉ69.19 crore compared to a loss of βΉ37.94 crore in the previous quarter. Revenue from operations surged to βΉ713.24 crore as the company moved out of the seasonal off-period and Unit 1 resumed operations in November 2025. The company successfully utilized βΉ519.37 crore of its βΉ750 crore IPO proceeds towards capex and working capital. Furthermore, a strategic Joint Venture agreement was executed with Sumitomo Corporation for its gas subsidiary.
- Consolidated Revenue from Operations grew to βΉ713.24 crore in Q3 FY26 from βΉ114.86 crore in Q2 FY26.
- Net Profit for the quarter stood at βΉ69.19 crore, rebounding from a sequential loss of βΉ37.94 crore.
- IPO proceeds of βΉ519.37 crore utilized out of βΉ750 crore, with βΉ140.13 crore spent on capital expenditure.
- Executed JV agreement with Sumitomo Corporation for a 49% equity interest in TruAlt Gas Private Limited.
- Unit 1 became operational in November 2025 following dual-feed capability conversion; Units 2, 4, and 5 are yet to reach normalized levels.
Financial Performance
Revenue Growth by Segment
Consolidated revenue for H1 FY26 was INR 418 Cr, a 26% decline from INR 585 Cr in H1 FY25. Ethanol segment revenue declined 28% due to strategic shutdowns. Conversely, the CBG segment grew 65% YoY, with revenue increasing from INR 12.53 Cr to INR 20.71 Cr in H1 FY26.
Geographic Revenue Split
Operations are primarily based in Karnataka and Maharashtra, where seven project locations have been jointly identified for the GAIL JV rollout.
Profitability Margins
Consolidated PAT margin was -7.29% in H1 FY26 compared to -6.52% in H1 FY25. However, the CBG segment achieved a positive PAT margin of 49.85% in Q2 FY26, up from -1.51% in Q2 FY25. Management expects long-term PAT margins to stabilize at 30-35%.
EBITDA Margin
Consolidated EBITDA margin improved despite the revenue drop, driven by the CBG segment which reported a 68.29% EBITDA margin in H1 FY26. Standalone EBITDA margin for Q2 FY26 was -11.29% compared to 4.89% in Q2 FY25.
Capital Expenditure
External term debt exceeded INR 1,500 Cr as of March 2025 to build 2,000 KLPD ethanol capacity. Planned expansion includes 17 additional CBG plants and a Sustainable Aviation Fuel (SAF) plant expected to commission by August/September 2027.
Credit Rating & Borrowing
CRISIL Ratings maintains a 'Stable' outlook. Finance costs increased 13% YoY to INR 38.59 Cr in Q2 FY26. Post-IPO, gearing is expected to improve from 2.5x in FY25 to approximately 1x in FY26.
Operational Drivers
Raw Materials
Key raw materials include Bagasse (used for power generation), Multi-grain (maize and rice), and Sugarcane/Molasses. Switching to bagasse-based power saved INR 11 Cr in fuel costs.
Import Sources
Sourced domestically, primarily from Karnataka and Maharashtra, utilizing decentralized sourcing and feedstock assurance frameworks.
Key Suppliers
Feedstock is secured through the MRN Group ecosystem and decentralized sourcing networks; offtake is primarily through OMCs like GAIL, ONGC, and HPCL.
Capacity Expansion
Current installed capacity is 2,000 KLPD, with 1,300 KLPD recently converted to dual-feed (multi-grain) capability. Planned expansion includes 17 more CBG plants and a 310 KLPD SAF plant.
Raw Material Costs
Raw material costs for Q2 FY26 were INR 92.07 Cr, representing 71% of total income. Procurement strategies focus on multi-feed flexibility to mitigate seasonal grain/molasses price volatility.
Manufacturing Efficiency
CBG plants are operating at 80% capacity utilization. Ethanol uptime is projected to increase by 114% to 136% following the multi-feed conversion.
Logistics & Distribution
Saved INR 7-8 Cr by eliminating coal transportation costs through the adoption of bagasse-based power.
Strategic Growth
Expected Growth Rate
17%
Growth Strategy
Growth will be driven by increasing ethanol production volume from 41 Cr to 48 Cr liters, scaling the CBG vertical with 17 new plants, and entering the Sustainable Aviation Fuel (SAF) market by FY28 using Honeywell UOP technology.
Products & Services
Ethanol, Compressed Bio-Gas (CBG), Extra Neutral Alcohol (ENA), Distillers Dried Grains with Solubles (DDGS), and Bagasse-based Power.
Brand Portfolio
TruAlt Bioenergy, Leafiniti Bioenergy (subsidiary).
New Products/Services
Sustainable Aviation Fuel (SAF) expected to contribute to revenue starting FY28; DDGS integration provides a new high-protein animal feed revenue stream.
Market Expansion
Downstream retail expansion with 13 outlets going operational in Phase 1 of a 100-outlet rollout plan.
Strategic Alliances
Joint Ventures with GAIL and Sumitomo for CBG rollout; technology transfer agreement with Honeywell UOP for SAF production.
External Factors
Industry Trends
The industry is shifting toward green energy and diversified feedstocks. TruAlt is positioned as a leader in the transition from seasonal sugar-based ethanol to year-round multi-grain production.
Competitive Landscape
Part of the MRN Group; competes with other large-scale distilleries but differentiates through CBG and SAF diversification.
Competitive Moat
Moat is built on multi-feed flexibility (1,300 KLPD) and strategic JVs with state-run entities (GAIL), providing feedstock security and guaranteed offtake that competitors lack.
Macro Economic Sensitivity
Highly sensitive to agricultural output and government biofuel mandates (E20 blending targets).
Consumer Behavior
Increasing demand for green energy and ethanol-blended fuels driven by environmental awareness and government mandates.
Geopolitical Risks
Trade barriers on grain exports/imports could affect feedstock pricing and availability.
Regulatory & Governance
Industry Regulations
Subject to government ethanol procurement pricing, pollution control board norms for distilleries, and biofuel blending mandates.
Environmental Compliance
Focus on ESG through CBG production and SAF; multi-feed conversion helps meet government environmental mandates for biofuels.
Risk Analysis
Key Uncertainties
Regulatory risk regarding ethanol pricing (high impact); feedstock price volatility for maize and rice (medium impact).
Geographic Concentration Risk
High concentration in Karnataka and Maharashtra for current and planned project rollouts.
Third Party Dependencies
High dependency on OMCs for ethanol offtake and GAIL/Sumitomo for CBG project execution.
Technology Obsolescence Risk
Mitigated by technology partnership with Honeywell UOP for next-generation SAF production.
Credit & Counterparty Risk
Receivables are primarily from OMCs, indicating high credit quality despite the recent decline in receivable turnover due to shutdowns.